Tolosa P, Pascual T, Martinez-Saez O, Hernando C, et al. Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study. Eur J Cancer 2025 Jan 3:115219. doi: 10.1016/j.ejca.2024.115219.
PMID: 39779447